Investing in GLP-1 Innovations and the $1 Trillion Metabolic Health Opportunity
As GLP-1 therapies reshape consumer behavior and health outcomes, a far larger opportunity is emerging at the intersection of food, health, and medicine. The session is hosted by the UC Davis-anchored Food and Health Angels, a new early-stage investment group of entrepreneurs, venture capitalists, and business leaders who have founded, funded, and built world class companies in the food and health space. Join us to explore the $1 trillion metabolic health growth opportunity and where investors are placing their bets next.
Host
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)